Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Epidemiology of multiple sclerosis].
A Disproportionate Burden of Care: Gender Differences in Mental Health, Health-Related Quality of Life, and Social Support in Mexican Multiple Sclerosis Caregivers.
Role of executive functions in prospective memory in multiple sclerosis: Impact of the strength of cue-action association.
Chronic inflammatory demyelinating polyneuropathy in common variable immunodeficiency.
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
Microglia, physiology and behavior: A brief commentary.
[The results of an open prospective study of β-interferon biosimilars (an Yaroslavl' cohort)].
Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.
New Developments in Murine Imaging for Assessing Photoreceptor Degeneration In Vivo.
Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: "A rare combination of two uncommon disorders".
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Antiphospholipid antibodies: paradigm in transition.
Autoimmune neuropathies: insights from animal models.
Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report.
Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS.
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Multiple Sclerosis: Changes in Thalamic Resting-State Functional Connectivity Induced by a Home-based Cognitive Rehabilitation Program.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports.

Pages